Your browser doesn't support javascript.
loading
Evaluation of MTBH, a novel hesperetin derivative, on the activity of hepatic cytochrome P450 isoform in vitro and in vivo using a cocktail method by HPLC-MS/MS.
Qin, Yan; Dong, Haijun; Sun, Jiayin; Zhang, Yilong; Li, Jun; Zhang, Tianci; Chen, Guanjun; Wang, Sheng; Song, Shuai; Wang, Wei; Fan, Yuru; Wang, Jie; Huang, Xiaohui; Shen, Chenlin.
Afiliación
  • Qin Y; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, Institute for Liver Diseases of Anhui Medical University, Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Dong H; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, Institute for Liver Diseases of Anhui Medical University, Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Sun J; Nanjing cantech Microbial Sci.& Tech. Co., Ltd, Nanjing, China.
  • Zhang Y; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, Institute for Liver Diseases of Anhui Medical University, Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Li J; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, Institute for Liver Diseases of Anhui Medical University, Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Zhang T; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, Institute for Liver Diseases of Anhui Medical University, Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Chen G; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, Institute for Liver Diseases of Anhui Medical University, Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Wang S; Center for Scientific Research of Anhui Medical University, Hefei, P.R. China.
  • Song S; Center for Scientific Research of Anhui Medical University, Hefei, P.R. China.
  • Wang W; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, Institute for Liver Diseases of Anhui Medical University, Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Fan Y; Department of Pharmacy, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Wang J; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, Institute for Liver Diseases of Anhui Medical University, Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, China.
  • Huang X; Genrix (Shanghai) Biopharmaceutical Co., Ltd, Shanghai, P.R. China.
  • Shen C; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, Institute for Liver Diseases of Anhui Medical University, Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, China.
Xenobiotica ; 51(12): 1389-1399, 2021 Dec.
Article en En | MEDLINE | ID: mdl-34806938
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hesperidina Límite: Animals Idioma: En Revista: Xenobiotica Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hesperidina Límite: Animals Idioma: En Revista: Xenobiotica Año: 2021 Tipo del documento: Article País de afiliación: China